Skip to main content
Equibles
ARGX logo

ARGX · Argenx SE

Track ARGX — free

Use ARGX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ARGX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$851.29 -5.65 (-0.66%) At close · Aug 14
Market Cap
$52.69B
Shares
62.19M

Argenx SE Earnings Call Transcripts

Every quarterly earnings call for Argenx SE (ARGX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Conference
Investor event
2026-06-09
argenx to Present at Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
argenx to Present at William Blair 46th Annual Growth Stock Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2025-12-31
Argenx SE Q4 FY2025 Earnings Call
Confident tone VYVGART franchise growth and patient reach MG label expansion (seronegative and ocular) CIDP momentum and label update
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Argenx SE Q3 FY2025 Earnings Call
Confident tone VYVGART commercial momentum Upcoming 2026 registrational readouts Pipeline expansion and Phase III assets
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Argenx SE Q2 FY2025 Earnings Call
Confident tone VYVGART commercial performance CIDP launch progress Indication breadth - myositis, Sjogren's, TED
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Argenx SE Q1 FY2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Argenx SE Q4 FY2024 Earnings Call
Confident tone VYVGART commercial momentum and launch execution Pipeline expansion and innovation engine Empasiprubart (C2 inhibitor) registrational strategy
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Argenx SE Q3 FY2024 Earnings Call
Confident tone CIDP launch (VYVGART Hytrulo) VYVGART commercial momentum (gMG) Pipeline and pipeline expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Argenx SE Q2 FY2024 Earnings Call
Confident tone CIDP launch Vision 2030 and long-term growth ambitions Clinical trial execution and inherent risks
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Argenx SE Q1 FY2024 Earnings Call
Confident tone VYVGART commercial growth Pre-filled syringe and label expansion Clinical pipeline expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Argenx SE Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Argenx SE Q3 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Argenx SE Q2 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Argenx SE Q1 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Argenx SE Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q2
2022-06-30
Argenx SE Q2 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Argenx SE Q1 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Argenx SE Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Argenx SE Q3 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Argenx SE Q2 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Argenx SE Q1 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Argenx SE Q4 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q2
2020-06-30
Argenx SE Q2 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Argenx SE Q1 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–24 of 24 earnings calls
Key facts CIK 1697862 CUSIP 04016X101 13F (30d) 489 filings 463 filers Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)